Evidence map›Paper›PMID 23916828›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2013

Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring.

Woottichai Khamduang, Catherine Gaudy-Graffin, Nicole Ngo-Giang-Huong, Gonzague Jourdain, Alain Moreau, Thitiporn Borkird, Prapaisri Layangool, Nareerat Kamonpakorn, Weerachai Jitphiankha, Ratchanee Kwanchaipanich and 5 more

Abstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Woottichai KhamduangFaculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand; INSERM U966, CHRU Tours, Faculté de Médecine, Université François-Rabelais, Tours, France; Institut de Recherche pour le Développement (IRD) UMI 174/Programs for HIV Prevention and Treatment (PHPT), Chiang Mai, Thailand.
Catherine Gaudy-Graffin
Nicole Ngo-Giang-Huong
Gonzague Jourdain
Alain Moreau
Thitiporn Borkird
Prapaisri Layangool
Nareerat Kamonpakorn
Weerachai Jitphiankha
Ratchanee Kwanchaipanich
Sathit Potchalongsin
Marc Lallemant
Wasna Sirirungsi
Alain Goudeau
Program for HIV Prevention and Treatment (PHPT) group
Chiang Mai University · THCentre Hospitalier Universitaire de Tours · FRBhumibol Adulyadej Hospital · THHarvard University · USHatyai Hospital · THInserm · FRThai Health Promotion Foundation · THUniversité de Tours · FR

Funding

NEVIRAPINE+ZIDOVUDINE--PREVENT PERINATAL HIV IN THAILANDR01HD039615 · NICHD · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LALLEMANT, MARC J · 2000 to 2002
$3.7M
SHORT ZDV COURSE TO PREVENT PERINATAL HIV IN THAILANDR01HD033326 · NICHD · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LALLEMANT, MARC J · 1996 to 2000
$368k
HBV, HCV, CMV &HHV-8 IN HIV POSITIVE WOMEN IN THAILANDR03TW001346 · FIC · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LALLEMANT, MARC J · 2000 to 2001
$81k
FIC NIH HHS R03 TW001346FIC NIH HHS R03 TW01346NICHD NIH HHS 5 R01 HD 39615NICHD NIH HHS R01 HD033326NICHD NIH HHS R01 HD039615
6 · The paper itself

Abstract

backgroundDespite implementation of universal infant hepatitis B (HB) vaccination, mother-to-child transmission (MTCT) of hepatitis B virus (HBV) still occurs. Limited data are available on the residual MTCT of HBV in human immunodeficiency virus (HIV)-HBV co-infected women.

objectivesWe assessed the prevalence of HBV infection among HIV-infected pregnant women and the rate of residual MTCT of HBV from HIV-HBV co-infected women and analyzed the viral determinants in mothers and their HBV-infected children. STUDY

designHIV-1 infected pregnant women enrolled in two nationwide perinatal HIV prevention trials in Thailand were screened for HB surface antigen (HBsAg) and tested for HBeAg and HBV DNA load. Infants born to HBsAg-positive women had HBsAg and HBV DNA tested at 4-6 months. HBV diversity within each HBV-infected mother-infant pair was analyzed by direct sequencing of amplified HBsAg-encoding gene and cloning of amplified products.

resultsAmong 3312 HIV-1 infected pregnant women, 245 (7.4%) were HBsAg-positive, of whom 125 were HBeAg-positive. Of 230 evaluable infants born to HBsAg-positive women, 11 (4.8%) were found HBsAg and HBV DNA positive at 4-6 months; 8 were born to HBeAg-positive mothers. HBV genetic analysis was performed in 9 mother-infant pairs and showed that 5 infants were infected with maternal HBV variants harboring mutations within the HBsAg "a" determinant, and four were infected with wild-type HBV present in highly viremic mothers.

conclusionsHBV-MTCT still occurs when women have high HBV DNA load and/or are infected with HBV variants. Additional interventions targeting highly viremic women are thus needed to reduce further HBV-MTCT.

Indexed as

Infectious Disease Transmission, VerticalAdultDNA, ViralFemaleHepatitis B, ChronicHepatitis B e AntigensHepatitis B Surface AntigensHepatitis B virusHIV InfectionsHumansInfantInfant, NewbornPregnancyPregnancy Complications, InfectiousPrevalenceThailandDNA, ViralHepatitis B e AntigensHepatitis B Surface Antigens95%CI95% confidence intervaldeoxyribonucleic acidDNAEPIexpanded program on immunizationHBHBeAgHBIgHBsAgHBs antigen variantsHBVhepatitis Bhepatitis B immune globulinHepatitis B vaccine failurehepatitis B virusHIVHIV pregnant womenhuman immunodeficiency virusinterquartile rangeIQRmother-to-child transmissionMother-to-child transmissionMTCTPCRpolymerase chain reactionThailandthe “e” antigen of the hepatitis B virusthe surface antigen of the hepatitis B virus

Identifiers

PMID23916828
PMCPMC3872003
OpenAlexW2018119385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.